Recombinant Human PARM1 Protein，His

PARM1 (Progestin and AdipoQ Receptor Membrane Protein 1) is a relatively newly identified protein that has garnered significant interest in the fields of cell biology and cancer research. Initially discovered as a protein associated with progestin signaling, PARM1 plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Recent studies have highlighted its potential involvement in tumorigenesis, particularly in breast and prostate cancers, where altered expression levels of PARM1 have been linked to aggressive disease phenotypes. Additionally, PARM1 has been implicated in immune responses and metabolic regulation, further expanding its significance beyond oncological contexts. Researchers have focused on the structural and functional characterization of PARM1, leading to efforts in recombinant protein production for downstream applications such as antibody generation and potential therapeutic interventions. By employing techniques like gene cloning, expression in bacterial or eukaryotic systems, and subsequent purification protocols, scientists aim to elucidate the mechanistic pathways influenced by PARM1 and assess its viability as a biomarker or therapeutic target. Understanding the roles of PARM1 at the molecular level is essential for developing innovative strategies in cancer treatment and improving prognostic assessments. Overall, ongoing research into PARM1 recombinant proteins is crucial for unraveling its multifaceted roles in health and disease, paving the way for novel therapeutic approaches.